Zhang Yali, Xu Yingying, Hu Ling, Wang Xiaomei
Tianyou Hospital, Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
Hubei Province Key Laboratory of Occupational Hazard Identification and Control, College of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China.
Front Pediatr. 2025 Feb 6;13:1508613. doi: 10.3389/fped.2025.1508613. eCollection 2025.
Recurrent respiratory tract infections (RRTIs) are a common condition in pediatrics and significantly impact children's quality of life; however, their pathogenesis and contributing factors are not yet fully elucidated. Probiotics have recently emerged as promising agents for modulating intestinal microecology and have gained considerable attention in clinical research on preventing and treating RRTIs in children. This article provides an initial overview of the concept, classification, and mechanisms underlying probiotics. It emphasizes their beneficial effects on respiratory health by modulating intestinal microbial equilibrium, augmenting immune system functionality, and attenuating inflammatory responses. Subsequently, we examine existing research regarding the use of probiotics in pediatric RRTIs. Numerous clinical trials have unequivocally demonstrated that supplementing with probiotics can significantly reduce both the frequency and severity of RRTIs in children while also simultaneously decreasing antibiotic usage. However, there are ongoing controversies and challenges in current research concerning the influence of probiotic type, dosage, duration of use, and other factors on efficacy. Furthermore, variations have been observed across different studies. Additionally, it is crucial to further evaluate the safety and potential long-term side effects associated with probiotic use in children with RRTIs. In conclusion, we propose future research directions including conducting more high-quality randomized controlled trials to optimize application strategies for probiotics alongside other treatments while considering variations based on age and health conditions among pediatric populations. Finally, in summary although probiotics exhibit promising benefits in preventing and treating RRTIs in children; additional studies are necessary to refine their application strategies ensuring both safety and effectiveness.
反复呼吸道感染(RRTIs)是儿科常见病症,对儿童生活质量有显著影响;然而,其发病机制和相关因素尚未完全阐明。益生菌最近已成为调节肠道微生态的有前景的制剂,并在儿童RRTIs防治的临床研究中受到广泛关注。本文初步概述了益生菌的概念、分类及其潜在机制。强调了它们通过调节肠道微生物平衡、增强免疫系统功能和减轻炎症反应对呼吸道健康的有益作用。随后,我们审视了关于益生菌在儿科RRTIs中应用的现有研究。众多临床试验明确表明,补充益生菌可显著降低儿童RRTIs的发作频率和严重程度,同时还能减少抗生素的使用。然而,目前关于益生菌类型、剂量、使用时长及其他因素对疗效的影响的研究仍存在争议和挑战。此外,不同研究之间也存在差异。此外,进一步评估益生菌在RRTIs儿童中使用的安全性和潜在长期副作用至关重要。总之,我们提出未来的研究方向,包括开展更多高质量随机对照试验,以优化益生菌与其他治疗方法联合使用的应用策略,同时考虑儿科人群中基于年龄和健康状况的差异。最后,尽管益生菌在预防和治疗儿童RRTIs方面显示出有前景的益处,但仍需更多研究来完善其应用策略,确保安全性和有效性。